Researchers have conducted groundbreaking research on memristor-based brain-computer interfaces (BCIs). This research presents an innovative approach for implementing energy-efficient adaptive ...

Cognixion, a developer of noninvasive brain-computer interface technology, has launched a clinical study that integrates its EEG-based brain-computer interface with Apple Vision Pro. The study aims to ...

June 2 (UPI) --Paradromics, a competitor of Neuralink, announced Monday it safely implanted a brain-computer interface into a human patient and recorded neural activity, before removing it 10 minutes ...

Please provide your email address to receive an email when new articles are posted on . The Stentrode brain-computer interface offers a non-invasive, nonsurgical solution for paralysis. Additional ...

China’s brain-computer interface industry is growing fast, and the newest company to emerge from the country is aiming to access the brain without the use of invasive implants. Gestala, newly founded ...

Brain-computer interface (BCI) technology is opening an unprecedented chapter in human-machine integration by establishing direct communication between the brain and external devices. Once a science ...

New York-based Synchron, a brain-computer interface (BCI) company, has raised $200 million in Series D funding, bringing its total raise to $345 million. Double Point Ventures led the round, with ...

Researchers researchers bring noninvasive EEG-based BCI one step closer to everyday use by demonstrating real-time brain decoding of individual finger movement intentions and control of a dexterous ...

Inbrain Neuroelectronics signed a pact with Microsoft to use the tech giant’s Azure AI infrastructure to advance the Spanish company’s graphene-based brain-computer interface (BCI) technology. Inbrain ...

While Elon Musk’s Neuralink likes to say it’s “pioneering” brain-computer interfaces (BCIs), China’s BCI industry is already quietly moving from research to scale. A new wave of startups is racing to ...

Synchron has reeled in another $200 million in a series D round—cash the company said it will use to expand operations and accelerate commercialization of its nonsurgical brain-computer interface (BCI ...